Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities-Reference-Cited by-同舟云学术

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities

Published:2021-07-06 Issue:1 Volume:326 Page:46
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Cohen Myron S.¹,Nirula Ajay²,Mulligan Mark J.³,Novak Richard M.⁴,Marovich Mary⁵,Yen Catherine⁵,Stemer Alexander⁶,Mayer Stockton M.⁴,Wohl David¹,Brengle Blair⁷,Montague Brian T.⁸,Frank Ian⁹,McCulloh Russell J.¹⁰,Fichtenbaum Carl J.¹¹,Lipson Brad¹²,Gabra Nashwa¹³,Ramirez Julio A.¹⁴,Thai Christine¹⁵,Chege Wairimu⁵,Gomez Lorenzo Margarita M.⁵,Sista Nirupama¹⁶,Farrior Jennifer¹⁶,Clement Meredith E.¹⁷,Brown Elizabeth R.¹⁸,Custer Kenneth L.²,Van Naarden Jacob²,Adams Andrew C.²,Schade Andrew E.²,Dabora Matan C.²,Knorr Jack²,Price Karen L.²,Sabo Janelle²,Tuttle Jay L.²,Klekotka Paul²,Shen Lei²,Skovronsky Daniel M.²,Gyamfi Kwadwo-Agyei¹⁹,Begue Jason¹⁹,Borgetti Scott¹⁹,Burkholder Greer¹⁹,Edupuganti Srilatha¹⁹,Gannon Kathleen¹⁹,Hall Christopher¹⁹,Horstman Victoria¹⁹,Hussain Rubaba¹⁹,Mena Leandro¹⁹,Merritt Tina¹⁹,Montano Charles¹⁹,Morris Jason¹⁹,Patel Meenakshi¹⁹,Rashid Ayesha¹⁹,Solomon Hormoz¹⁹,Som Mousumi¹⁹,Taffet George¹⁹,

Affiliation:

1. Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill

2. Eli Lilly and Co, Indianapolis, Indiana

3. New York University Langone Vaccine Center, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, New York

4. University of Illinois College of Medicine, Chicago

5. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland

6. Indiana University School of Medicine, Gary

7. Brengle Family Medicine, Indianapolis, Indiana

8. Division of Infectious Diseases, University of Colorado School of Medicine, Aurora

9. Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia

10. University of Nebraska Medical Center, Omaha

11. University of Cincinnati Academic Health Center, Cincinnati, Ohio

12. Florida Primary and Specialty Care, Boca Raton

13. Burke Internal Medicine & Research, Burke, Virginia

14. Division of Infectious Diseases, University of Louisville School of Medicine, Louisville, Kentucky

15. private practice, Huntington Beach, California

16. FHI 360, Durham, North Carolina

17. Louisiana State University Health Sciences Center, New Orleans

18. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

19. for the BLAZE-2 Investigators

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2780870/jama_cohen_2021_oi_210061_1625172038.59986.pdf

Reference27 articles.

1. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility.;Arons;N Engl J Med,2020

2. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes.;Graham;J Infect,2020

3. Epidemiology of Covid-19 in a long-term care facility in King County, Washington.;McMichael;N Engl J Med,2020

4. Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19.;Panagiotou;JAMA Intern Med,2021

5. Risk factors associated with mortality among residents with coronavirus disease 2019 (COVID-19) in long-term care facilities in Ontario, Canada.;Fisman;JAMA Netw Open,2020

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials of pharmacological interventions for SARS‐CoV‐2 published in leading medical journals report adherence but not how it was assessed;British Journal of Clinical Pharmacology;2024-01-25

2. Antiandrogens as Therapies for COVID-19: A Systematic Review;Cancers;2024-01-10

3. Antiviral therapy of coronavirus disease 2019 (COVID-19);Journal of the Formosan Medical Association;2024-01

4. An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic;International Journal of Molecular Sciences;2023-12-26

5. Anti-SARS-CoV-2 Antibody Testing: Role and Indications;Journal of Clinical Medicine;2023-12-08